This content is machine translated Cardiovascular primary prevention Do not use aspirin indiscriminately The benefits of acetylsalicylic acid (ASA) in the secondary prevention of atherosclerotic cardiovascular disease are considered proven. In primary prevention, however, the evidence is controversial. The current tenor is: routine…
View Post 5 min This content is machine translated Nonspecific reactions with drugs Allergy or non-allergy, that is the question here When a patient reacts to the administration of a drug, the question for the treating physician is always whether it is an allergy or a non-specific reaction. Ultimately, this will…
View Post 4 min This content is machine translated Upper respiratory tract comorbidities When asthma and rhinosinusitis go hand in hand Almost half (45%) of all patients with – mainly severe – asthma are also affected by chronic rhinosinusitis with nasal polyps (CRSwNP). As many as 60% have allergic rhinitis as a…
View Post 3 min This content is machine translated Cardiovascular diseases New study data on primary prophylaxis with ASA: carefully weigh benefits and risks Acetylsalicylic acid (ASA) has long been established for the secondary prevention of cardiovascular events. In contrast, ASA administration for primary prevention is controversial. While European experts tend to advise against…
View Post 3 min This content is machine translated High-risk cardiology patients Facts and Figures on Antithrombotic Therapy Anticoagulation is associated with many challenges – even more so when patients belong to a high-risk group. This is because the combination of different preparations can be associated with risks,…
View Post 3 min This content is machine translated Antiplatelet agents Ticagrelor reduces risk of recurrent stroke After an acute cerebral infarction or a transient ischemic attack (TIA), the risk of another stroke is massively increased. That early treatment with an antiplatelet agent contributes to secondary prevention…
View Post 2 min This content is machine translated Coronary heart disease Place of omega-3 fatty acids and aspirin in primary prevention. Hypertension, elevated blood lipids or diabetes are among the risk factors of CHD. Omega-3 fatty acid substitution and aspirin administration are preferred as primary prevention. But is that still in…
View Post 5 min This content is machine translated Stable and unstable aneurysms Growing understanding of disease through new studies The disease understanding of intracranial aneurysms is changing. In formation and growth, as well as in destabilization mechanisms, inflammatory processes are currently the focus of clinical research. Recent findings could…
View Post 8 min This content is machine translated 40 years of percutaneous coronary intervention Update on indications, outcomes, and concomitant drug therapy. With PCI, mortality in acute coronary syndrome has been impressively reduced. An overview of current technical developments (stents), key treatment guidelines, and adjunctive therapies. Includes overview interventional vs surgical treatment…
View Post 8 min This content is machine translated Focal neurological deficit Acute treatment of ischemic stroke Successful stroke treatment is carried out in dedicated centers (stroke units and stroke centers) by an experienced and specialized team. The standard of care in the acute phase is systemic…
View Post 6 min This content is machine translated After the heart attack What medication does the patient need? Heart attack patients should receive aspirin 100 mg and the maximum tolerated statin dose for life. Regardless of the type of revascularization, all myocardial infarction patients should take a P2Y12 inhibitor…
